iBio Inc News

The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 07:00 ET

Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.

1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.

cls.cnNov 15 15:02 ET

Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.

① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.

cls.cnNov 14 20:37 ET

IBio GAAP EPS of -$0.46 In-line

Seeking AlphaNov 12 18:13 ET

Express News | IBio Q1 EPS $(0.46) Beats $(0.48) Estimate

BenzingaNov 12 16:52 ET

iBio Inc | 10-Q: Q1 2025 Earnings Report

SECNov 12 16:32 ET · Announcements

IBio 1Q Rev $0.00 >IBIO

Dow JonesNov 12 16:31 ET

Express News | Ibio Inc: Qtrly Shr Loss From Cont Ops $0.46

ReutersNov 12 16:10 ET

Press Release: IBio Reports Fiscal First Quarter 2025 Financial Results

Dow JonesNov 12 16:05 ET

Earnings Week Ahead: DIS, BABA, JD, CSCO, HD, OXY, SU, SHOP, AMAT, SPOT, and More

Seeking AlphaNov 10 08:01 ET

Express News | IBio And AstralBio Say They 'Have Identified a Molecule With Therapeutic Potential for Treating Muscle Wasting and Obesity, Which Is Designed for Subcutaneous Administration and Has Potential for an Extended Half-life'; Are Working On Plans To Advance...

BenzingaOct 10 08:06 ET

Express News | Ibio Inc - Has Exclusive Option to License Three Cardiometabolic Targets From Astralbio

ReutersOct 10 08:02 ET

Express News | Ibio Inc - Aims to File Ind Application for Myostatin Program by End of 2025

ReutersOct 10 08:01 ET

Express News | Ibio Inc - Plans Non-Cgmp in Vivo Studies With Early 2025 Readouts

ReutersOct 10 08:01 ET

Express News | Ibio and Astralbio Provide Update on Myostatin Program for Obesity

ReutersOct 10 08:00 ET

IBio and AstralBio Provide Update on Myostatin Program for Obesity

GlobeNewswireOct 10 08:00 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaOct 7 08:08 ET

iBio Inc | 10-K/A: Annual report (Amendment)

SECSep 24 16:17 ET · Announcements

AAR, ShiftPixy And 3 Stocks To Watch Heading Into Monday

BenzingaSep 23 04:47 ET

iBio Inc | 10-K: FY2024 Annual Report

SECSep 20 16:19 ET · Announcements